phrykt

Krystal Biotech, Inc. (KRYS): who owns it and who trades it

As of Nov 16, 2026, KRYS insiders reported 125 open-market sales worth $95.2M and no purchases in the last 12 months, with 86% of the sale value made under pre-set 10b5-1 plans. The largest seller was Suma Krishnan (President), with $34.3M. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Krystal Biotech

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns KRYS

418 funds and institutions reported KRYS shares worth $11B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is FMR LLC (Fidelity) with 15.0%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

FMR LLC (Fidelity)15.0%
BlackRock, Inc.14.2%
Avoro Capital Advisors LLC9.8%
Vanguard Portfolio Management LLC5.3%
State Street Corp4.6%
Vanguard Capital Management LLC4.2%
Soleus Capital Management, L.P.3.2%
Capital World Investors2.6%
Geode Capital Management, LLC2.4%
T. Rowe Price Associates2.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
FMR LLC (Fidelity)4.42M14.99%$1.6B+1%
BlackRock, Inc.4.18M14.18%$1.6B+6%
Avoro Capital Advisors LLC2.89M9.80%$1.1BNo change
Vanguard Portfolio Management LLC1.57M5.34%$585M+8%
State Street Corp1.35M4.58%$502M+3%
Vanguard Capital Management LLC1.24M4.21%$461M+6%
Soleus Capital Management, L.P.939,2543.19%$349M-19%
Capital World Investors777,8432.64%$289M-6%
Geode Capital Management, LLC698,9932.37%$260M+9%
T. Rowe Price Associates687,4002.33%$255M+42%
Hood River Capital Management LLC663,3752.25%$247M+7%
Redmile Group, LLC632,0052.14%$235M-6%
William Blair Investment Management, LLC570,1531.93%$212M+40%
Frazier Life Sciences Management, L.P.481,3071.63%$179MNo change
Dimensional Fund Advisors LP476,0381.61%$177M+2%
First Trust Advisors LP324,9001.10%$121M-7%
Invesco Ltd.324,7551.10%$121M+29%
Goldman Sachs Group Inc298,8411.01%$111M+39%
Northern Trust Corp283,7840.96%$105M+12%
Franklin Resources Inc261,9170.89%$97.3M+46%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, KRYS insiders reported $0 of open-market purchases and $95.2M of sales. 86% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$95.2M
125 trades, 6 people
Sales under a 10b5-1 plan
86%
Share of sale value
Latest trade
Sep 4, 2026
Filed Sep 4, 2026

Purchases and sales by month

$27.8M$27.8MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 4, 2026Suma KrishnanPresidentSale plan1,992$362.65$722KForm 4
Sep 4, 2026Suma KrishnanPresidentSale plan1,242$361.61$449KForm 4
Sep 4, 2026Suma KrishnanPresidentSale plan2,320$360.47$836KForm 4
Sep 4, 2026Suma KrishnanPresidentSale plan3,392$359.39$1.2MForm 4
Sep 4, 2026Suma KrishnanPresidentSale plan3,180$358.42$1.1MForm 4
Sep 4, 2026Suma KrishnanPresidentSale plan3,962$357.57$1.4MForm 4
Sep 4, 2026Suma KrishnanPresidentSale plan565$363.34$205KForm 4
Sep 4, 2026Suma KrishnanPresidentSale plan2,006$355.57$713KForm 4
Sep 4, 2026Suma KrishnanPresidentSale plan520$354.54$184KForm 4
Sep 4, 2026Suma KrishnanPresidentSale plan1,329$364.48$484KForm 4
Sep 4, 2026Suma KrishnanPresidentSale plan826$365.41$302KForm 4
Sep 4, 2026Suma KrishnanPresidentSale plan399$366.56$146KForm 4
Sep 4, 2026Suma KrishnanPresidentSale plan3,267$356.37$1.2MForm 4
Sep 4, 2026Krish S KrishnanCEOSale plan1,358$364.48$495KForm 4
Sep 4, 2026Krish S KrishnanCEOSale plan847$365.42$310KForm 4
Sep 4, 2026Krish S KrishnanCEOSale plan405$366.56$148KForm 4
Sep 4, 2026Krish S KrishnanCEOSale plan2,029$355.57$721KForm 4
Sep 4, 2026Krish S KrishnanCEOSale plan3,297$356.37$1.2MForm 4
Sep 4, 2026Krish S KrishnanCEOSale plan3,981$357.57$1.4MForm 4
Sep 4, 2026Krish S KrishnanCEOSale plan3,143$358.42$1.1MForm 4
Sep 4, 2026Krish S KrishnanCEOSale plan3,357$359.39$1.2MForm 4
Sep 4, 2026Krish S KrishnanCEOSale plan2,266$360.46$817KForm 4
Sep 4, 2026Krish S KrishnanCEOSale plan1,214$361.61$439KForm 4
Sep 4, 2026Krish S KrishnanCEOSale plan2,010$362.65$729KForm 4
Sep 4, 2026Krish S KrishnanCEOSale plan573$363.34$208KForm 4
Aug 14, 2026Dino A RossiDirectorSale40$333.23$13.3KForm 4
Aug 14, 2026Dino A RossiDirectorSale3,095$331.43$1MForm 4
Aug 14, 2026Dino A RossiDirectorSale4,896$330.36$1.6MForm 4
Aug 14, 2026Dino A RossiDirectorSale7,428$329.60$2.4MForm 4
Aug 14, 2026Dino A RossiDirectorSale1,687$328.52$554KForm 4
Aug 14, 2026Dino A RossiDirectorSale5,226$327.39$1.7MForm 4
Aug 14, 2026Dino A RossiDirectorSale2,287$326.60$747KForm 4
Aug 14, 2026Dino A RossiDirectorSale341$325.60$111KForm 4
Jun 25, 2026John Charles ThomasVice presidentSale plan1,000$347.27$347KForm 4
Jun 4, 2026Suma KrishnanPresidentSale plan320$300.75$96.2KForm 4
Jun 4, 2026Suma KrishnanPresidentSale plan593$302.25$179KForm 4
Jun 4, 2026Suma KrishnanPresidentSale plan247$303.17$74.9KForm 4
Jun 4, 2026Suma KrishnanPresidentSale plan400$304.89$122KForm 4
Jun 4, 2026Suma KrishnanPresidentSale plan480$305.87$147KForm 4
Jun 4, 2026Suma KrishnanPresidentSale plan240$311.65$74.8KForm 4
Jun 4, 2026Suma KrishnanPresidentSale plan12,729$307.81$3.9MForm 4
Jun 4, 2026Suma KrishnanPresidentSale plan3,803$308.89$1.2MForm 4
Jun 4, 2026Suma KrishnanPresidentSale plan2,801$309.95$868KForm 4
Jun 4, 2026Suma KrishnanPresidentSale plan2,039$310.94$634KForm 4
Jun 4, 2026Suma KrishnanPresidentSale plan1,348$307.09$414KForm 4
Jun 4, 2026Krish S KrishnanCEOSale plan640$302.24$193KForm 4
Jun 4, 2026Krish S KrishnanCEOSale plan176$303.17$53.4KForm 4
Jun 4, 2026Krish S KrishnanCEOSale plan40$312.23$12.5KForm 4
Jun 4, 2026Krish S KrishnanCEOSale plan964$311.36$300KForm 4
Jun 4, 2026Krish S KrishnanCEOSale plan2,652$310.43$823KForm 4
Jun 4, 2026Krish S KrishnanCEOSale plan2,784$309.49$862KForm 4
Jun 4, 2026Krish S KrishnanCEOSale plan4,830$308.47$1.5MForm 4
Jun 4, 2026Krish S KrishnanCEOSale plan544$304.81$166KForm 4
Jun 4, 2026Krish S KrishnanCEOSale plan589$306.33$180KForm 4
Jun 4, 2026Krish S KrishnanCEOSale plan11,461$307.68$3.5MForm 4
May 26, 2026John Charles ThomasVice presidentSale plan642$302.03$194KForm 4
Mar 4, 2026Suma KrishnanPresidentSale plan407$257.32$105KForm 4
Mar 4, 2026Suma KrishnanPresidentSale plan589$258.54$152KForm 4
Mar 4, 2026Suma KrishnanPresidentSale plan668$259.61$173KForm 4
Mar 4, 2026Suma KrishnanPresidentSale plan3,667$260.37$955KForm 4
Mar 4, 2026Suma KrishnanPresidentSale plan1,700$266.42$453KForm 4
Mar 4, 2026Suma KrishnanPresidentSale plan1,938$262.35$508KForm 4
Mar 4, 2026Suma KrishnanPresidentSale plan2,248$263.58$593KForm 4
Mar 4, 2026Suma KrishnanPresidentSale plan4,852$264.64$1.3MForm 4
Mar 4, 2026Suma KrishnanPresidentSale plan6,000$265.16$1.6MForm 4
Mar 4, 2026Suma KrishnanPresidentSale plan2,931$261.41$766KForm 4
Mar 4, 2026Krish S KrishnanCEOSale plan483$257.31$124KForm 4
Mar 4, 2026Krish S KrishnanCEOSale plan470$258.38$121KForm 4
Mar 4, 2026Krish S KrishnanCEOSale plan1,377$259.87$358KForm 4
Mar 4, 2026Krish S KrishnanCEOSale plan3,128$260.49$815KForm 4
Mar 4, 2026Krish S KrishnanCEOSale plan920$266.56$245KForm 4
Mar 4, 2026Krish S KrishnanCEOSale plan2,380$262.44$625KForm 4
Mar 4, 2026Krish S KrishnanCEOSale plan2,043$263.70$539KForm 4
Mar 4, 2026Krish S KrishnanCEOSale plan8,798$264.85$2.3MForm 4
Mar 4, 2026Krish S KrishnanCEOSale plan2,439$265.59$648KForm 4
Mar 4, 2026Krish S KrishnanCEOSale plan2,962$261.41$774KForm 4
Mar 2, 2026Kathryn RomanoChief Accounting OfficerSale plan750$267.60$201KForm 4
Feb 27, 2026Daniel JanneyDirectorSale plan2,373$276.17$655KForm 4
Feb 27, 2026Daniel JanneyDirectorSale plan9,430$275.45$2.6MForm 4
Feb 26, 2026Daniel JanneyDirectorSale plan2,638$276.32$729KForm 4
Feb 26, 2026Daniel JanneyDirectorSale plan5,103$275.28$1.4MForm 4
Feb 25, 2026Daniel JanneyDirectorSale plan700$275.00$192KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan2,425$274.90$667KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan1,674$268.67$450KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan930$269.50$251KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan1,891$267.37$506KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan4,339$266.62$1.2MForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan1,604$265.54$426KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan900$264.60$238KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan62$263.05$16.3KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan373$271.09$101KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan370$269.83$99.8KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan569$262.91$150KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan1,733$264.12$458KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan3,557$265.08$943KForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan8,986$266.18$2.4MForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan11,673$266.97$3.1MForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan6,671$268.04$1.8MForm 4
Feb 24, 2026Daniel JanneyDirectorSale plan3,963$268.97$1.1MForm 4
Feb 19, 2026Dino A RossiDirectorSale10,834$262.10$2.8MForm 4

Latest 100 of 125 trades in the last 12 months.

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Suma KrishnanPresident, R&D, Director, 10% owner–$34.3MSep 4, 2026
Krish S KrishnanPresident and CEO, Director, 10% owner–$24.2MSep 4, 2026
Daniel JanneyDirector–$19.4MFeb 27, 2026
Dino A RossiDirector–$13.2MAug 14, 2026
Kathryn RomanoChief Accounting Officer–$3.6MMar 2, 2026
John Charles ThomasEVP, General Counsel–$541KJun 25, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

KRYS short interest

High short interest. 10.3% of KRYS shares are sold short: about 1 share in 10. Over the last 12 reports the number of shares short went down 4%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 3.04M KRYS shares were sold short, 10.3% of the shares outstanding, up 3.7% from the report before. At the average daily volume of 248,952 shares, buying them all back would take about 12.2 trading days (days to cover).

Shares short, % of all shares

10.3%May 15Oct 3012.2%

Days to cover

12.2May 15Oct 3018.0

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20263.04M10.28%+4%248,95212.2
Oct 15, 20262.94M9.92%-16%284,20910.3
Sep 30, 20263.48M11.74%+10%310,50211.2
Sep 15, 20263.16M10.69%-6%239,12913.2
Aug 31, 20263.35M11.31%+4%219,24515.3
Aug 14, 20263.20M10.83%+0%310,63610.3
Jul 31, 20263.20M10.82%-8%770,9664.2
Jul 15, 20263.50M11.86%-1%307,16011.4
Jun 30, 20263.52M11.93%+12%489,2557.2
Jun 15, 20263.14M10.65%-0%288,94510.9
May 29, 20263.15M10.68%-1%194,30516.2
May 15, 20263.18M10.80%+3%397,2308.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Krystal Biotech company events

Krystal Biotech filed 9 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 2, 2026.

  1. Nov 2, 2026ResultsReleased financial results. Filing
  2. Oct 15, 2026AnnouncementShared information with investors. Filing
  3. Aug 3, 2026ResultsReleased financial results. Filing
  4. Jul 21, 2026AnnouncementKrystal Biotech, Inc. filed with the U.S. Patent and Trademark Office a response to an Office Action in connection with a published patent application relating to KB801, the Company’s investigational gene therapy product candidate for the treatment of neurotrophic keratitis. Filing
  5. May 20, 2026VoteReported shareholder vote results. Filing
  6. Feb 17, 2026ResultsReleased financial results. Filing
  7. Jan 12, 2026ResultsReleased financial results. Filing
  8. Jan 8, 2026AnnouncementShared information with investors. Filing
  9. Dec 23, 2025LeadershipKirti Ganorkar gave notice of his resignation from the Board of Directors of Krystal Biotech, Inc. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Krystal Biotech financials

Famous investors that hold KRYS

4 of the 50 well-known investors we track reported holding KRYS in their latest 13F filing. The largest position is Ray Dalio's, worth $33.2M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ray Dalio · Bridgewater AssociatesQ3 202699,920$33.2M0.1%+83%
Jim Simons · Renaissance TechnologiesQ3 202663,120$21M0.0%+6%
Ken Griffin · Citadel AdvisorsQ3 202644,548$14.8M0.0%+1535%
Ken Fisher · Fisher Asset ManagementQ3 202626,952$9M0.0%-3%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named KRYS in the last 120 days.

FiledHolderFormStake
Oct 30, 2026Vanguard Portfolio Management13G/A4.4%
Oct 30, 2026Vanguard Portfolio Management13G/A4.4%
Oct 27, 2026BlackRock, Inc.13G/A11.6%
Oct 27, 2026BlackRock, Inc.13G/A11.6%

Questions about Krystal Biotech, Inc. (KRYS) stock

Who owns the most KRYS stock?

The largest reported owner of Krystal Biotech, Inc. (KRYS) is FMR LLC (Fidelity), with 15.0% of the company. In total, 418 funds and institutions reported holding KRYS at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are KRYS insiders buying or selling?

In the last 12 months, KRYS insiders reported no open-market purchases and 125 sales worth $95.2M. The latest trade was on Sep 4, 2026. See every trade.

What is the short interest in KRYS?

As of Oct 30, 2026, 3.04M KRYS shares were sold short, 10.3% of the shares outstanding, up 3.7% from the report before. At the average daily volume of 248,952 shares, buying them all back would take about 12.2 trading days (days to cover). See the history.

Which famous investors hold KRYS?

4 of the 50 well-known investors we track reported KRYS in their latest 13F filing, including Ray Dalio, Jim Simons, Ken Griffin. The largest position is worth $33.2M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.